First report of proton beam therapy for breast angiosarcoma from the prospective PCG registry

Acta Oncol. 2018 Jul;57(7):992-994. doi: 10.1080/0284186X.2017.1423179. Epub 2018 Jan 5.

Authors

Cameron S Thorpe¹, Joshua R Niska¹, Daniel C Brunnhoelzl², Lisa A McGee¹, Christy M Kesslering³, William F Hartsell³, Carlos E Vargas¹

Affiliations

¹ a Department of Radiation Oncology , Mayo Clinic , Phoenix , AZ , USA.
² b Creighton University School of Medicine at St. Joseph's Hospital and Medical Center , Phoenix , AZ , USA.
³ c Northwestern Medicine Chicago Proton Center , Warrenville , IL , USA.

PMID: 29303019
DOI: 10.1080/0284186X.2017.1423179

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Aged
Breast Neoplasms / pathology
Breast Neoplasms / radiotherapy*
Breast Neoplasms / surgery
Female
Hemangiosarcoma / pathology
Hemangiosarcoma / radiotherapy*
Hemangiosarcoma / surgery
Humans
Mastectomy, Segmental
Middle Aged
Pain / etiology
Prospective Studies
Proton Therapy* / adverse effects
Radiodermatitis / etiology
Radiodermatitis / pathology
Radiotherapy, Adjuvant
Registries

Supplementary concepts

Angiosarcoma of the breast